Anyone with a health condition that might have made it unsafe or challenging to participate was left out of the semaglutide clinical trials, for example, according to the study protocol, a precaution similar to other clinical trials
FDA-APPROVED INDICATIONS Type 2 diabetes As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus Limitations of use: has not been studied in patients with a history of pancreatitis TYPE 2 DIABETES RCT SURPASS-2 trial - Tirzepatide vs Semaglutide in Patients with Type 2 Diabetes, NEJM (2021) [PubMed abstract] The SURPASS-2 trial enrolled 1879 adults with type 2 diabetes who were inadequately controlled with metformin at a dose of at least 1500 mg per day Main inclusion criteria Age 18 years T2DM uncontrolled with metformin at 1500 mg/day A1C of 7 - 10.5% BMI 25 and stable for 3 months Main exclusion criteria Type 1 diabetes GFR 50 ng/L
Is this a replacement for a balanced diet
Safety and Monitoring Checklist For either route, track objective data: Fasting glucose and/or A1c IGF-1 labs Blood pressure Fluid retention/edema Joint discomfort or carpal tunnel-like symptoms Sleep quality and recovery markers If stacking GH-axis compounds, increase lab frequency and lower starting doses
At the molecular level, here is how it protects and rebuilds your nervous system: The Methionine Reaction: Vitamin B12 is required by an enzyme called methionine synthase
During your visit, our teamincluding experienced providers like Dr